Cynthia S. Goldsmith, Russell Regner/CDC via AP
Biden administration has announced “enhanced nationwide vaccination strategy” to curb the spread of monkeypox in the US
Speaking to reporters on Tuesday, top federal health officials — including director of the Centers for Disease Control and Prevention, Dr. Rochelle Walensky and Dr. Ashish Jha, the White House’s Covid-19 Response Coordinator – outlined the government’s plan to increase the availability of a monkeypox vaccine.
The Department of Health and Human Services will make 296,000 doses available in the coming weeks — within that amount, 56,000 doses will be made available immediately — and expects a total of 1.6 million doses to be available in the US by the end of the year. The vaccine being distributed is the JYNNEOS vaccine, which is given in two doses 28 days apart.
There are now more than 300 confirmed cases of monkeypox in the US, according to the CDC.
As NPR has reported, a lack of monkey pox testing means the outbreak is likely larger than the number of cases suggests.
No deaths from monkeypox have been reported in the US during the current outbreak.
Under this new strategy, the vaccine will now be given to people with confirmed and suspected monkeypox exposure. That includes “those who have had close physical contact with someone who has been diagnosed with monkeypox, those who know their sexual partner has been diagnosed with monkeypox, and men who have had sex with men who have recently had multiple sex partners in a location where they have been known to or in an area where monkeypox is spreading,” according to an HHS press release.